Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial

Sophy T F Shih; Nathalie Davis-Lameloise; Edward D. Janus; Carol Wildey; Vincent L. Versace; Virginia Hagger; Dino Asproloupos; Sharleen L. O'Reilly; Paddy A. Phillips; Michael Ackland; Timothy Skinner; Jeremy Oats; Rob Carter; James D. Best; James A. Dunbar

doi:10.1186/1745-6215-15-259

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial

Sophy T F Shih, Nathalie Davis-Lameloise, Edward D. Janus, Carol Wildey, Vincent L. Versace, Virginia Hagger, Dino Asproloupos, Sharleen L. O'Reilly, Paddy A. Phillips, Michael Ackland, Timothy Skinner, Jeremy Oats, Rob Carter, James D. Best, James A. Dunbar^*

^*Corresponding author for this work

8 Citations (Scopus)

Abstract

Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes.Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion " surgical or medical intervention to treat obesity" has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.Trial registration: Australian New Zealand Clinical Trials Registry ANZCTRN 12610000338066.

Original language	English
Article number	259
Journal	Trials
Volume	15
Issue number	1
ISSN	1745-6215
DOIs	https://doi.org/10.1186/1745-6215-15-259
Publication status	Published - 30 Jun 2014

Keywords

Gestational diabetes
Lifestyle intervention
Post-natal
Type 2 diabetes prevention

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/1745-6215-15-259Licence: CC BY

1745-6215-15-259Final published version, 244 KBLicence: CC BY

Cite this

Shih, S. T. F., Davis-Lameloise, N., Janus, E. D., Wildey, C., Versace, V. L., Hagger, V., Asproloupos, D., O'Reilly, S. L., Phillips, P. A., Ackland, M., Skinner, T., Oats, J., Carter, R., Best, J. D., & Dunbar, J. A. (2014). Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial. Trials, 15(1), [259]. https://doi.org/10.1186/1745-6215-15-259

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention : An update to the study protocol for a randomized controlled trial. / Shih, Sophy T F; Davis-Lameloise, Nathalie; Janus, Edward D. et al.

In: Trials, Vol. 15, No. 1, 259, 30.06.2014.

Research output: Contribution to journal › Journal article › Research › peer-review

Shih, STF, Davis-Lameloise, N, Janus, ED, Wildey, C, Versace, VL, Hagger, V, Asproloupos, D, O'Reilly, SL, Phillips, PA, Ackland, M, Skinner, T, Oats, J, Carter, R, Best, JD & Dunbar, JA 2014, 'Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial', Trials, vol. 15, no. 1, 259. https://doi.org/10.1186/1745-6215-15-259

@article{7399ac2f0ba84e5383e6fd8cec82e840,

title = "Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial",

abstract = "Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes.Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion {"} surgical or medical intervention to treat obesity{"} has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.Trial registration: Australian New Zealand Clinical Trials Registry ANZCTRN 12610000338066.",

keywords = "Gestational diabetes, Lifestyle intervention, Post-natal, Type 2 diabetes prevention",

author = "Shih, {Sophy T F} and Nathalie Davis-Lameloise and Janus, {Edward D.} and Carol Wildey and Versace, {Vincent L.} and Virginia Hagger and Dino Asproloupos and O'Reilly, {Sharleen L.} and Phillips, {Paddy A.} and Michael Ackland and Timothy Skinner and Jeremy Oats and Rob Carter and Best, {James D.} and Dunbar, {James A.}",

year = "2014",

month = jun,

day = "30",

doi = "10.1186/1745-6215-15-259",

language = "English",

volume = "15",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention

T2 - An update to the study protocol for a randomized controlled trial

AU - Shih, Sophy T F

AU - Davis-Lameloise, Nathalie

AU - Janus, Edward D.

AU - Wildey, Carol

AU - Versace, Vincent L.

AU - Hagger, Virginia

AU - Asproloupos, Dino

AU - O'Reilly, Sharleen L.

AU - Phillips, Paddy A.

AU - Ackland, Michael

AU - Skinner, Timothy

AU - Oats, Jeremy

AU - Carter, Rob

AU - Best, James D.

AU - Dunbar, James A.

PY - 2014/6/30

Y1 - 2014/6/30

N2 - Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes.Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion " surgical or medical intervention to treat obesity" has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.Trial registration: Australian New Zealand Clinical Trials Registry ANZCTRN 12610000338066.

AB - Background: The Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) is a randomized controlled trial (RCT) that aims to assess the effectiveness of a structured diabetes prevention intervention for women who had gestational diabetes.Methods/Design: The original protocol was published in Trials (http://www.trialsjournal.com/content/14/1/339). This update reports on an additional exclusion criterion and change in first eligibility screening to provide greater clarity. The new exclusion criterion " surgical or medical intervention to treat obesity" has been added to the original protocol. The risks of developing diabetes will be affected by any medical or surgical intervention as its impact on obesity will alter the outcomes being assessed by MAGDA-DPP. The screening procedures have also been updated to reflect the current recruitment operation. The first eligibility screening is now taking place either during or after pregnancy, depending on recruitment strategy.Trial registration: Australian New Zealand Clinical Trials Registry ANZCTRN 12610000338066.

KW - Gestational diabetes

KW - Lifestyle intervention

KW - Post-natal

KW - Type 2 diabetes prevention

UR - http://www.scopus.com/inward/record.url?scp=84903330345&partnerID=8YFLogxK

U2 - 10.1186/1745-6215-15-259

DO - 10.1186/1745-6215-15-259

M3 - Journal article

C2 - 24981503

AN - SCOPUS:84903330345

SN - 1745-6215

VL - 15

JO - Trials

JF - Trials

IS - 1

M1 - 259

ER -

Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: An update to the study protocol for a randomized controlled trial

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this